Original ArticleGreen synthesis of gold nanoparticles using chlorogenic acid and their enhanced performance for inflammation
Graphical Abstract
- •
The caffeic acid moiety of CGA mediates the formation of CGA-AuNPs without chemical reductants through a two-electron oxidation during the reduction of Au3 + to AuNPs.
- •
CGA-AuNPs exhibit enhanced anti-inflammatory activity in vitro and in vivo through NF-κB down-regulation compared to CGA.
Section snippets
Reagents and cells
Raw 264.7 cells, widely used murine macrophages, were obtained from the Korean Cell Line Bank (KCLB) and grown in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco BRL) supplemented with 10% fetal bovine serum (FBS; Gibco BRL) and penicillin (100 U/mL)/streptomycin (100 μg/mL) (Gibco BRL). Lipopolysaccharide (LPS), CGA, Griess reagent, caffeic acid, (−)-quinic acid, and hydrochloroauric acid trihydrate (HAuCl4 · 3H2O) were purchased from Sigma–Aldrich (St. Louis, MO, USA). All other reagents were of
UV-Visible, FT-IR Spectra and HR-XRD analysis of CGA-AuNPs
CGA (1) is composed of two natural compounds, caffeic acid (2) and (−)-quinic acid (3), linked through an ester bond (Figure 1, A). When CGA was used as a reductant, the CGA-AuNPs turned pink in color and exhibited a characteristic surface plasmon resonance band with maximum absorbance at 545 nm (Figure 1, B, line ii), whereas no color change was observed in the solution without the reductant (Figure 1, B, line i). The FT-IR spectrum of CGA standard was described in our previous report.17 As
Discussion
CGA has been reported in various functions such as anti-oxidant, anti-aging, and anti-diabetic.11, 12 For instance, it slows the release of glucose into the blood, helping counter the accumulation of body fat caused by excess blood glucose and reduce the risk of diabetes. Recently, the anti-inflammatory effect of CGA has been reported in LPS-inflamed murine macrophage cells, mouse retinal inflammation model, carbon tetrachloride (CCl4)-induced liver fibrosis model, and LPS-inflamed
References (30)
- et al.
Gold nanoparticles: a paradigm shift in biomedical applications
Adv Colloid Interf Sci
(2013) - et al.
Gold nanoparticles: emerging paradigm for targeted drug delivery system
Biotechnol Adv
(2013) - et al.
Biological synthesis of metal nanoparticles by microbes
Adv Colloid Interf Sci
(2010) - et al.
Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation
Biochem Pharmacol
(2013) - et al.
Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264.7 cells
Nitric Oxide
(2010) - et al.
Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice
J Biol Chem
(2014) - et al.
Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway
Toxicology
(2013) - et al.
Synthesis of gold nanoparticles with glycosides: synthetic trends based on the structures of glycones and aglycones
Carbohydr Res
(2014) - et al.
Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles
Nanomedicine
(2012) - et al.
The golden age: gold nanoparticles for biomedicine
Chem Soc Rev
(2012)
Multifunctional gold nanoparticles for diagnosis and therapy of disease
Mol Pharm
Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy
Chem Soc Rev
Gold nanoparticles: assembly, supremolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology
Chem Rev
Biological applications of gold nanoparticles
Chem Soc Rev
Polysaccharides and phytochemicals: a natural reservoir for the green synthesis of gold and silver nanoparticles
IET Nanobiotechnol
Cited by (0)
Financial support: This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korean Government, the Ministry of Education (2012R1A1A2042224) and the Ministry of Science, ICT & Future Planning (2013R1A1A1059709 and 2010-18282).
- 1
These authors contributed equally to this work.